India Pharma Outlook Team | Saturday, 14 December 2024
The increasing use of AI technologies in the healthcare sector aids in diagnostics market growth. Additionally, the demand for quicker diagnosis procedures can positively influence the market. AI promotes advancements in radiology, pathology, cardiology, and cancer detection. The international market for AI in diagnostics was assessed at USD 1.40 billion in 2024 and is anticipated to reach approximately USD 10.15 billion by 2033.
The integration of AI technologies in diagnostic methods has transformed medical diagnosis. AI in diagnostics pertains to utilizing AI technologies to improve the diagnostic process. Utilizing AI and machine learning (ML) algorithms within diagnostic tools examines extensive amounts of data from diverse sources, including genetic data, patient histories, and medical images, yielding insights for precise and effective diagnosis.
As the demand for advanced imaging methods increases, the adoption of AI and ML algorithms in diagnostic tools is becoming more common, as they facilitate real-time analysis of medical data. The advancement of machine learning and natural language processing technologies has improved AI functions in diagnostics, resulting in comprehensive insights into disease trends. Additionally, the growing prevalence of chronic diseases globally and the heightened awareness regarding early detection and prevention of diseases are expected to enhance market growth in the upcoming years.